Publications

First-in-class ruthenium anticancer drug (KP1339/IT-139) induces an immunogenic cell death signature in colorectal spheroids in vitro

Author(s)
Debora Wernitznig, Konstantinos Kiakos, Giorgia Del Favero, Nathalie Harrer, Herwig Machat, Annika Osswald, Michael A. Jakupec, Andreas Wernitznig, Wolfgang Sommergruber, Bernhard K. Keppler
Organisation(s)
Department of Inorganic Chemistry, Department of Food Chemistry and Toxicology
External organisation(s)
Boehringer Ingelheim Austria, Research Cluster Translational Cancer Therapy Research
Journal
Metallomics: integrated biometal science
Volume
11
Pages
1044-1048
No. of pages
5
ISSN
1756-5901
DOI
https://doi.org/10.1039/c9mt00051h
Publication date
06-2019
Peer reviewed
Yes
Austrian Fields of Science 2012
104003 Inorganic chemistry, 301904 Cancer research, 106023 Molecular biology
Keywords
ASJC Scopus subject areas
Metals and Alloys, Chemistry (miscellaneous), Biophysics, Biochemistry, Biomaterials
Sustainable Development Goals
SDG 3 - Good Health and Well-being
Portal url
https://ucris.univie.ac.at/portal/en/publications/firstinclass-ruthenium-anticancer-drug-kp1339it139-induces-an-immunogenic-cell-death-signature-in-colorectal-spheroids-in-vitro(e5110f11-9113-4cc9-8f5d-4154adc19ac5).html

Projects

First-in-class ruthenium anticancer drug (KP1339/IT-139) induces an immunogenic cell death signature in colorectal spheroids in vitro

Author(s)
Debora Wernitznig, Konstantinos Kiakos, Giorgia Del Favero, Nathalie Harrer, Herwig Machat, Annika Osswald, Michael A. Jakupec, Andreas Wernitznig, Wolfgang Sommergruber, Bernhard K. Keppler
Organisation(s)
Department of Inorganic Chemistry, Department of Food Chemistry and Toxicology
External organisation(s)
Boehringer Ingelheim Austria, Research Cluster Translational Cancer Therapy Research
Journal
Metallomics: integrated biometal science
Volume
11
Pages
1044-1048
No. of pages
5
ISSN
1756-5901
DOI
https://doi.org/10.1039/c9mt00051h
Publication date
06-2019
Peer reviewed
Yes
Austrian Fields of Science 2012
104003 Inorganic chemistry, 301904 Cancer research, 106023 Molecular biology
Keywords
ASJC Scopus subject areas
Metals and Alloys, Chemistry (miscellaneous), Biophysics, Biochemistry, Biomaterials
Sustainable Development Goals
SDG 3 - Good Health and Well-being
Portal url
https://ucris.univie.ac.at/portal/en/publications/firstinclass-ruthenium-anticancer-drug-kp1339it139-induces-an-immunogenic-cell-death-signature-in-colorectal-spheroids-in-vitro(e5110f11-9113-4cc9-8f5d-4154adc19ac5).html

Talks

First-in-class ruthenium anticancer drug (KP1339/IT-139) induces an immunogenic cell death signature in colorectal spheroids in vitro

Author(s)
Debora Wernitznig, Konstantinos Kiakos, Giorgia Del Favero, Nathalie Harrer, Herwig Machat, Annika Osswald, Michael A. Jakupec, Andreas Wernitznig, Wolfgang Sommergruber, Bernhard K. Keppler
Organisation(s)
Department of Inorganic Chemistry, Department of Food Chemistry and Toxicology
External organisation(s)
Boehringer Ingelheim Austria, Research Cluster Translational Cancer Therapy Research
Journal
Metallomics: integrated biometal science
Volume
11
Pages
1044-1048
No. of pages
5
ISSN
1756-5901
DOI
https://doi.org/10.1039/c9mt00051h
Publication date
06-2019
Peer reviewed
Yes
Austrian Fields of Science 2012
104003 Inorganic chemistry, 301904 Cancer research, 106023 Molecular biology
Keywords
ASJC Scopus subject areas
Metals and Alloys, Chemistry (miscellaneous), Biophysics, Biochemistry, Biomaterials
Sustainable Development Goals
SDG 3 - Good Health and Well-being
Portal url
https://ucris.univie.ac.at/portal/en/publications/firstinclass-ruthenium-anticancer-drug-kp1339it139-induces-an-immunogenic-cell-death-signature-in-colorectal-spheroids-in-vitro(e5110f11-9113-4cc9-8f5d-4154adc19ac5).html